BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 89.49 |
| Open | 90.03 |
| Bid | 91.95 x 100 |
| Ask | 92.14 x 100 |
| Day's Range | 89.99 - 92.21 |
| 52 Week Range | 76.02 - 99.56 |
| Volume | |
| Avg. Volume | 1,403,535 |
| Market Cap | 17.471B |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | 105.82 |
| EPS (TTM) | 0.87 |
| Earnings Date | Apr 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 110.14 |
ZacksIs a Surprise Coming for BioMarin (BMRN) This Earnings Season?
BioMarin (BMRN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ZacksAstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Sales of AstraZeneca's (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new indications.
ZacksGear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for BioMarin (BMRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.